BR9711560A - Compostos de heteariloxietiaminas processo de prepara-Æo dos mesmos uso dos mesmos e composi-{es farmac-uticas - Google Patents
Compostos de heteariloxietiaminas processo de prepara-Æo dos mesmos uso dos mesmos e composi-{es farmac-uticasInfo
- Publication number
- BR9711560A BR9711560A BR9711560A BR9711560A BR9711560A BR 9711560 A BR9711560 A BR 9711560A BR 9711560 A BR9711560 A BR 9711560A BR 9711560 A BR9711560 A BR 9711560A BR 9711560 A BR9711560 A BR 9711560A
- Authority
- BR
- Brazil
- Prior art keywords
- hetearyloxyethiamin
- pharmaceutical compositions
- preparation process
- same use
- compounds preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9611798A FR2753968B1 (fr) | 1996-09-27 | 1996-09-27 | Nouvelles heteroaryloxyethylamines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| PCT/FR1997/001691 WO1998013349A2 (fr) | 1996-09-27 | 1997-09-26 | Heteroaryloxyethylamines en tant que ligands 5-ht¿1a? |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9711560A true BR9711560A (pt) | 1999-08-24 |
Family
ID=9496126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9711560A BR9711560A (pt) | 1996-09-27 | 1997-09-26 | Compostos de heteariloxietiaminas processo de prepara-Æo dos mesmos uso dos mesmos e composi-{es farmac-uticas |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6063784A (pt) |
| EP (1) | EP0929525B1 (pt) |
| JP (1) | JP2001503393A (pt) |
| AR (1) | AR008486A1 (pt) |
| AT (1) | ATE223380T1 (pt) |
| AU (1) | AU731459B2 (pt) |
| BR (1) | BR9711560A (pt) |
| CA (1) | CA2267247C (pt) |
| DE (1) | DE69715223T2 (pt) |
| DK (1) | DK0929525T3 (pt) |
| ES (1) | ES2182120T3 (pt) |
| FR (1) | FR2753968B1 (pt) |
| HU (1) | HUP0001189A3 (pt) |
| IL (1) | IL128917A (pt) |
| MY (1) | MY118992A (pt) |
| NO (1) | NO311935B1 (pt) |
| NZ (1) | NZ334623A (pt) |
| PL (1) | PL190221B1 (pt) |
| RU (1) | RU2176639C2 (pt) |
| TW (1) | TW425390B (pt) |
| WO (1) | WO1998013349A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4507398B2 (ja) * | 1999-12-06 | 2010-07-21 | 宇部興産株式会社 | 3−ハロメチルオキセタン化合物の合成方法 |
| US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
| RU2234315C1 (ru) * | 2003-06-30 | 2004-08-20 | Государственный научный центр - Институт биофизики | Фармацевтическая композиция, содержащая ондансетрон, метацин и бензамид |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989003681A1 (en) * | 1987-10-19 | 1989-05-05 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma |
| DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
| MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
| US5240800A (en) * | 1991-07-29 | 1993-08-31 | Eastman Kodak Company | Near-infrared radiation sensitive photoelectrographic master and imaging method |
| EP0643045B1 (de) * | 1993-09-10 | 2000-03-08 | Novartis AG | Chinolin-Verbindungen als Leukotriene Antagonisten |
| GB9507288D0 (en) * | 1995-04-07 | 1995-05-31 | Sod Conseils Rech Applic | Phenoxyethylamine derivatives with high affinity for 5-HT1A receptors |
-
1996
- 1996-09-27 FR FR9611798A patent/FR2753968B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-24 AR ARP970104385A patent/AR008486A1/es unknown
- 1997-09-25 MY MYPI97004469A patent/MY118992A/en unknown
- 1997-09-26 CA CA002267247A patent/CA2267247C/fr not_active Expired - Fee Related
- 1997-09-26 US US09/254,787 patent/US6063784A/en not_active Expired - Fee Related
- 1997-09-26 DK DK97943000T patent/DK0929525T3/da active
- 1997-09-26 NZ NZ334623A patent/NZ334623A/en unknown
- 1997-09-26 DE DE69715223T patent/DE69715223T2/de not_active Expired - Lifetime
- 1997-09-26 TW TW086114116A patent/TW425390B/zh not_active IP Right Cessation
- 1997-09-26 ES ES97943000T patent/ES2182120T3/es not_active Expired - Lifetime
- 1997-09-26 EP EP97943000A patent/EP0929525B1/fr not_active Expired - Lifetime
- 1997-09-26 RU RU99108674/04A patent/RU2176639C2/ru not_active IP Right Cessation
- 1997-09-26 JP JP51535198A patent/JP2001503393A/ja not_active Withdrawn
- 1997-09-26 WO PCT/FR1997/001691 patent/WO1998013349A2/fr not_active Ceased
- 1997-09-26 BR BR9711560A patent/BR9711560A/pt active Search and Examination
- 1997-09-26 PL PL97332480A patent/PL190221B1/pl not_active IP Right Cessation
- 1997-09-26 HU HU0001189A patent/HUP0001189A3/hu unknown
- 1997-09-26 AT AT97943000T patent/ATE223380T1/de not_active IP Right Cessation
- 1997-09-26 IL IL12891797A patent/IL128917A/xx not_active IP Right Cessation
- 1997-09-26 AU AU44637/97A patent/AU731459B2/en not_active Ceased
-
1999
- 1999-03-26 NO NO19991481A patent/NO311935B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2182120T3 (es) | 2003-03-01 |
| FR2753968A1 (fr) | 1998-04-03 |
| PL190221B1 (pl) | 2005-11-30 |
| WO1998013349A3 (fr) | 1998-11-05 |
| CA2267247A1 (fr) | 1998-04-02 |
| AU731459B2 (en) | 2001-03-29 |
| EP0929525A2 (fr) | 1999-07-21 |
| IL128917A (en) | 2003-10-31 |
| NO991481D0 (no) | 1999-03-26 |
| RU2176639C2 (ru) | 2001-12-10 |
| AU4463797A (en) | 1998-04-17 |
| IL128917A0 (en) | 2000-02-17 |
| NO991481L (no) | 1999-03-26 |
| DE69715223T2 (de) | 2003-04-30 |
| ATE223380T1 (de) | 2002-09-15 |
| EP0929525B1 (fr) | 2002-09-04 |
| TW425390B (en) | 2001-03-11 |
| FR2753968B1 (fr) | 1998-11-27 |
| JP2001503393A (ja) | 2001-03-13 |
| DK0929525T3 (da) | 2002-12-02 |
| PL332480A1 (en) | 1999-09-13 |
| AR008486A1 (es) | 2000-01-19 |
| WO1998013349A2 (fr) | 1998-04-02 |
| CA2267247C (fr) | 2009-05-05 |
| MY118992A (en) | 2005-02-28 |
| DE69715223D1 (de) | 2002-10-10 |
| HUP0001189A3 (en) | 2001-12-28 |
| US6063784A (en) | 2000-05-16 |
| NZ334623A (en) | 1999-09-29 |
| NO311935B1 (no) | 2002-02-18 |
| HUP0001189A2 (hu) | 2000-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9611986A (pt) | Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos | |
| BR9602705A (pt) | Composto composição farmacéutica processo para a preparação de um composto e uso | |
| BR9508586A (pt) | Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica | |
| BR9611198A (pt) | Composto processo de preparação do mesmo e composição farmacêutica | |
| BR9707501A (pt) | Composto composição farmacêutica e uso do composto | |
| ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
| BR9707139A (pt) | Utilização de uma quantidade eficaz de uma associação composições processo de preparação de composições uso de um produto e artigos | |
| PT850948E (pt) | Derivados propiofenona e processo para a preparacao dos mesmos | |
| BR9406566A (pt) | Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica | |
| BR9603429A (pt) | Derivado de 11-(fenila substituída) estra-4,9-dieno processo de preparação do mesmo composição farmacêutica e uso deste derivado | |
| BR9509200A (pt) | Composição de matéria | |
| BR9706311A (pt) | Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética | |
| EE03380B1 (et) | Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod | |
| BR9600930A (pt) | Derivados de n-(3-benzofuranil)uréia processo para sua preparação composição processo para a preparação de composições e uso | |
| BRPI0107815B8 (pt) | compostos derivados aminados de di-hidro-1,3,5- triazina, processo de preparo destes, composição farmacêutica e uso dos mesmos | |
| BR9505107A (pt) | Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso | |
| BR9707808A (pt) | Composto composição farmacêutica e uso do composto | |
| FI971750A0 (fi) | Koostumuksia multippeliskleroosia varten ja sen hoito | |
| BR9708790A (pt) | Composto uso de um composto e formulação farmacêutica | |
| BR9708141A (pt) | Composto processo sua preparação uso de composto e composição famracêutica | |
| BR9707261A (pt) | Compostos processos de preparação dos mesmos e de produtos e composições farmacéuticas | |
| EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| EE9900034A (et) | Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine | |
| BR9610530A (pt) | Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos | |
| BR9600339A (pt) | Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |